Literature DB >> 29133969

Treatment of Chronic Lower Extremity Ulcers with A New Er:Yag Laser Technology.

J M Alcolea1,2, E Hernández3, P A Martínez-Carpio4,2, M Vélez5,2, V Khomchenko6, A Sola7, M A Trelles2.   

Abstract

Chronic lower extremity ulcers (CLEUs) have a high prevalence and are difficult to treat due to their various aetiologies. The aim of this study is to evaluate the results achieved in treating CLEUs using an Erbium: YAG (Er:YAG) laser with RecoSMA technology. This laser emits thousands of microbeams of energy causing superficial epidermal ablation and a separation of dermal fibres due to a mechanical-acoustic and resonance effect. The evaluation of the results achieved was carried out by questionnaires completed by 18 patients enrolled in the study. Histological studies and photographs taken before each session (16 sessions in total) were analysed to visually monitor the clinical progress. The analyses were carried out with the help of computer software. The results after 16 treatment sessions showed the complete healing of ulcers or a decrease in their initial area of at least 55% in over 65% of the patients treated. The Student's t-test and Fisher's exact test were used for statistical analysis. The Er:YAG laser and RecoSMA technology ablates few epidermal cell layers, producing a mechanical-acoustic effect with resonance action leading to tissue regeneration mechanisms. This technology offers an effective and safe alternative for treating CLEUs.

Entities:  

Keywords:  Chronic lower extremity ulcers; Er:YAG; RecoSMA technology; Ulcers; laser; mechanical-acoustic effect

Year:  2017        PMID: 29133969      PMCID: PMC5675912          DOI: 10.5978/islsm.17-OR-17

Source DB:  PubMed          Journal:  Laser Ther        ISSN: 0898-5901


  15 in total

1.  Low power laser therapy and analgesic action.

Authors:  G Tam
Journal:  J Clin Laser Med Surg       Date:  1999-02

2.  A clinical, histological, and computer-based assessment of the Polaris LV, combination diode, and radiofrequency system, for leg vein treatment.

Authors:  Neil S Sadick; Mario A Trelles
Journal:  Lasers Surg Med       Date:  2005-02       Impact factor: 4.025

Review 3.  Regulation of keratinocyte function by growth factors.

Authors:  K Hashimoto
Journal:  J Dermatol Sci       Date:  2000-12       Impact factor: 4.563

Review 4.  Laser therapy for venous leg ulcers.

Authors:  K Flemming; N Cullum
Journal:  Cochrane Database Syst Rev       Date:  2000

5.  Novel method for facial rejuvenation using Er:YAG laser equipped with a spatially modulated ablation module: An open prospective uncontrolled cohort study.

Authors:  N V Volkova; L K Glazkova; V V Khomchenko; N S Sadick
Journal:  J Cosmet Laser Ther       Date:  2016-12-05       Impact factor: 2.247

Review 6.  What's new: Management of venous leg ulcers: Approach to venous leg ulcers.

Authors:  Afsaneh Alavi; R Gary Sibbald; Tania J Phillips; O Fred Miller; David J Margolis; William Marston; Kevin Woo; Marco Romanelli; Robert S Kirsner
Journal:  J Am Acad Dermatol       Date:  2016-04       Impact factor: 11.527

7.  Validity of International Classification of Diseases, Ninth Revision, Clinical Modification codes for estimating the prevalence of venous ulcer.

Authors:  Monika L Gloviczki; Henna Kalsi; Peter Gloviczki; Matthew Gibson; Stephen Cha; John A Heit
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2014-05-10

8.  Management of Patients With Venous Leg Ulcers: Challenges and Current Best Practice.

Authors:  Peter J Franks; Judith Barker; Mark Collier; Georgina Gethin; Emily Haesler; Arkadiusz Jawien; Severin Laeuchli; Giovanni Mosti; Sebastian Probst; Carolina Weller
Journal:  J Wound Care       Date:  2016-06       Impact factor: 2.072

9.  A novel method of facial rejuvenation using a 2940-nm erbium:YAG laser with spatially modulated ablation: a pilot study.

Authors:  M A Trelles; V Khomchenko; J M Alcolea; P A Martínez-Carpio
Journal:  Lasers Med Sci       Date:  2016-07-01       Impact factor: 3.161

10.  Efficacy of nonablative laser treatment for rhytids: a controlled study with objective evaluation via clinical, profilometric, and computer assessments.

Authors:  Mario A Trelles; Jean-Luc Levy; Xavier Alvarez
Journal:  Aesthet Surg J       Date:  2006 Mar-Apr       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.